OVERSEA CHINESE BANKING Corp Ltd Grows Stock Holdings in UnitedHealth Group Incorporated $UNH

OVERSEA CHINESE BANKING Corp Ltd raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.3% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 52,573 shares of the healthcare conglomerate’s stock after buying an additional 6,969 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in UnitedHealth Group were worth $16,374,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Nabity Jensen Investment Management Inc raised its position in shares of UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after purchasing an additional 24 shares during the last quarter. Atlantic Edge Private Wealth Management LLC raised its position in shares of UnitedHealth Group by 8.9% in the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after purchasing an additional 25 shares during the last quarter. HHM Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after purchasing an additional 26 shares during the last quarter. Brogan Financial Inc. raised its position in shares of UnitedHealth Group by 3.4% in the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock valued at $429,000 after purchasing an additional 27 shares during the last quarter. Finally, West Wealth Group LLC raised its position in shares of UnitedHealth Group by 3.2% in the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock valued at $462,000 after purchasing an additional 27 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Barclays raised their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Royal Bank Of Canada reduced their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Finally, Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $385.13.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $362.78 on Monday. The company’s fifty day moving average price is $338.43 and its 200 day moving average price is $335.78. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a market capitalization of $328.56 billion, a P/E ratio of 15.72, a P/E/G ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business posted $6.80 EPS. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.